15 recruiting, 8 completed, 5 not yet recruiting, 3 unknown. 16 Not applicable, 6 Phase 2, 1 Phase 3.
Follow Centre Paul Strauss: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cerebral Connectivity and Metabolic Phenotype of Gliomas: Prospective Addition of DTI and Rs-fMRI to a Preoperative FDG PET Strategy, With Neuropsychological Correlates and Post-treatment Follow-up 18F-FDG PET/MRI with additional DTI and rs-fMRI sequences - Glioblastoma | Not applicable | Not yet recruiting | Centre Paul Strauss | 80 | 2026-09-15 | 2026-06-04 |
| Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas Administration of L-TC, HFRT alone - Sarcoma | Phase 2 | Not yet recruiting | Centre Paul Strauss | 42 | 2026-07-01 | 2026-06-04 |
| Evaluation of Two Methods of Administration of Photobiomodulation in the Context of the Prevention and Treatment of Mucositis Induced by Radiotherapy, During the Treatment of Head and Neck Cancers Photobiomodulation session - intraoral, Photobiomodulation session - transcutaneous - Head and Neck Neoplasms | Not applicable | Not yet recruiting | Centre Paul Strauss | 60 | 2026-06-15 | 2026-06-05 |
| Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study Simultaneous-integrated boost with IMRT - Glioblastoma | Phase 2 | Recruiting | Centre Paul Strauss | 54 | 2026-03-01 | 2026-02-04 |
| Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy Prospective questionnaires - Uterine Cervical Neoplasms | Recruiting | Centre Paul Strauss | 80 | 2025-11-17 | 2026-06-04 | |
| Effects of Chemotherapy Treatment on Metaboreflex, Mechanoreflex, and Baroreflex Function: PROTECT-08B Study Test of neuromuscular fatigue and associated hemodynamic responses - Breast Adenocarcinoma | Not applicable | Recruiting | Centre Paul Strauss | 24 | 2025-10-02 | 2025-12-31 |
| Evolution of Hypofractionated Stereotactic Irradiation for Radio-Resistant Brain Metastases From D1-3-5 to D1-2-3 D1-3-5 radiotherapy, D1-2-3 radiotherapy - Brain Metastases | Phase 3 | Not yet recruiting | Centre Paul Strauss | 264 | 2025-10-01 | 2025-09-11 |
| PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer TAP CT-scan, Bone scintigraphy, 18F-FDG PET-CT - Metastatic Breast Cancer, HER 2 Low-expressing Breast Cancer | Not applicable | Not yet recruiting | Centre Paul Strauss | 262 | 2025-09-01 | 2025-09-10 |
| Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma Integrated boost technique (SIB) guided by PET FDOPA - Glioblastoma Multiforme, Adult | Phase 2 | Recruiting | Centre Paul Strauss | 75 | 2025-06-23 | 2026-02-04 |
| Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B Anthracycline - Breast Neoplasms | Recruiting | Centre Paul Strauss | 50 | 2025-02-17 | 2026-02-04 | |
| Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck PCC - Head and Neck Cancer | Phase 2 | Recruiting | Centre Paul Strauss | 46 | 2025-01-24 | 2025-12-23 |
| Hippotherapy Teenager-pediatric Radiotherapy Participation in 10 horse-assisted therapy sessions - Radiotherapy | Not applicable | Recruiting | Centre Paul Strauss | 22 | 2024-06-19 | 2025-12-23 |
| Effects Of Concentric Cycling Training Protocol During (Neo)Adjuvant Chemotherapy in Breast Cancer Patients: PROTECT-07 Study Training sessions - Breast Cancer | Not applicable | Recruiting | Centre Paul Strauss | 156 | 2024-05-30 | 2026-02-02 |
| Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution CONTINUUM+ CONNECT remote monitoring - Prostatic Neoplasms, Lung Neoplasms | Not applicable | Completed | Centre Paul Strauss | 411 | 2024-04-25 | 2026-02-04 |
| Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer blood sampling before radiotherapy, blood sampling after the fourth radiotherapy session, collection of acute toxicity (radiodermatitis) - Triple-negative Breast Cancer | Not applicable | Active not recruiting | Centre Paul Strauss | 15 | 2024-01-11 | 2026-01-05 |
| Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC) 18-FDG PET-MRI - Cervical Cancer | Recruiting | Centre Paul Strauss | 50 | 2023-10-12 | 2026-02-02 | |
| Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma Immunotherapy - Head and Neck Cancer | Recruiting | Centre Paul Strauss | 60 | 2023-08-25 | 2026-06-05 | |
| Interest of PET-MRI in the Evaluation of the Response After Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma PET-MRI - Rectal Cancer | Recruiting | Centre Paul Strauss | 50 | 2023-05-19 | 2026-06-17 | |
| Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI Additional CEST sequences during PET/MRI exam - Glioma, Brain Metastases | Not applicable | Recruiting | Centre Paul Strauss | 800 | 2022-12-28 | 2026-02-02 |
| Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer Blood sample for genetic analysis - HER2-positive Breast Cancer | Recruiting | Centre Paul Strauss | 9000 | 2021-12-15 | 2026-06-04 |
Showing 20 of 33. Sign in to see all of them.
Breast Neoplasms (7) · Gallbladder Neoplasms (4) · Glioblastoma (3) · Head and Neck Neoplasms (3) · Brain Neoplasms (2) · Cholelithiasis (2) · Uterine Cervical Neoplasms (2) · Cardiotoxicity (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Fatigue (1) · Gastrointestinal Neoplasms (1) · Glioma (1) · Hyperphagia (1)
Anthracyclines (1) · Blood Specimen Collection (1) · Carboplatin (1) · Epirubicin (1) · Etoposide (1) · Genetic Testing (1) · Immunotherapy (1) · Observation (1) · Parenteral Nutrition (1) · Radiosurgery (1) · Radiotherapy (1) · Radiotherapy, Intensity-Modulated (1) · Sentinel Lymph Node Biopsy (1) · Technetium Tc 99m Sulfur Colloid (1) · iso-sulfan blue (1)
France (29) · Bolivia (4) · Chile (4) · Peru (4) · Germany (3) · Argentina (1) · Belgium (1)
PMID 17485709, PMID 32903594, PMID 38066522, PMID 40217880, PMID 40492859, PMID 41534624, PMID 42376805
2017 (1)